Literature DB >> 9302752

Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide entrapped in biodegradable polymer microspheres.

Y Men1, H Tamber, R Audran, B Gander, G Corradin.   

Abstract

We have previously reported that biodegradable polymer microspheres (MS) are capable of eliciting strong and long-lasting antibody and T cell proliferative responses for either natural protein antigens or synthetic peptides. In this study, we investigated the possibility of inducing antigen-specific cytotoxic T lymphocyte (CTL) responses in vivo with a short synthetic peptide from the circumsporozoite (CS) protein of Plasmodium berghei (Pb) 252-260 by using different MS formulations. We show that injection of mice with a short CTL epitope microencapsulated in MS or adsorbed on empty MS enhanced a specific CTL response comparable to that obtained with the incomplete Freund's adjuvant (IFA) formulation, indicating that MS are a potent antigen delivery system/immunostimulant for CTL response. These results might be of practical interest for MS preparation and development of subunit vaccines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9302752     DOI: 10.1016/s0264-410x(97)00047-9

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  Composition and surface charge of DNA-loaded microparticles determine maturation and cytokine secretion in human dendritic cells.

Authors:  Samantha Jilek; Michael Ulrich; Hans P Merkle; Elke Walter
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

2.  Injectable polymer microspheres enhance immunogenicity of a contraceptive peptide vaccine.

Authors:  Chengji Cui; Vernon C Stevens; Steven P Schwendeman
Journal:  Vaccine       Date:  2006-08-17       Impact factor: 3.641

3.  Enhancing efficacy of HIV gag DNA vaccine by local delivery of GM-CSF in murine and macaque models.

Authors:  Ruijiang Song; Shuqin Liu; Robert J Adams; Kam W Leong
Journal:  J Interferon Cytokine Res       Date:  2006-06       Impact factor: 2.607

4.  On technological and immunological benefits of multivalent single-injection microsphere vaccines.

Authors:  Gérard Boehm; Marisa Peyre; Dorothea Sesardic; Rachel J Huskisson; Fatme Mawas; Alexandra Douglas; Dorothy Xing; Hans P Merkle; Bruno Gander; Pål Johansen
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

5.  Biodegradable polylactide microspheres enhance specific immune response induced by Hepatitis B surface antigen.

Authors:  Shaohui Qiu; Qiang Wei; Zhenglun Liang; Guanghui Ma; Lianyan Wang; Wenqi An; Xiaowei Ma; Xin Fang; Peng He; Hemin Li; Zhongyu Hu
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

6.  Enhanced immunogenicity of microencapsulated tetanus toxoid with stabilizing agents.

Authors:  R Audran; Y Men; P Johansen; B Gander; G Corradin
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

7.  Phagocytosis and phagosomal fate of surface-modified microparticles in dendritic cells and macrophages.

Authors:  Lars Thiele; Hans P Merkle; Elke Walter
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

8.  Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy.

Authors:  Stacey L Demento; Stephanie C Eisenbarth; Harald G Foellmer; Craig Platt; Michael J Caplan; W Mark Saltzman; Ira Mellman; Michel Ledizet; Erol Fikrig; Richard A Flavell; Tarek M Fahmy
Journal:  Vaccine       Date:  2009-04-03       Impact factor: 3.641

Review 9.  Malaria vaccine adjuvants: latest update and challenges in preclinical and clinical research.

Authors:  Elena Mata; Aiala Salvador; Manoli Igartua; Rosa María Hernández; José Luis Pedraz
Journal:  Biomed Res Int       Date:  2013-04-23       Impact factor: 3.411

Review 10.  Oligomannose-coated liposome as a novel adjuvant for the induction of cellular immune responses to control disease status.

Authors:  Naoya Kojima; Mariko Ishii; Yoko Kawauchi; Hideaki Takagi
Journal:  Biomed Res Int       Date:  2013-10-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.